Document Detail

Mineralocorticoid receptor antagonists for therapy of coronary artery disease and related complications.
MedLine Citation:
PMID:  23333184     Owner:  NLM     Status:  Publisher    
The perception of aldosterone action to be restricted to regulation of fluid balance via sodium reabsorption and potassium excretion is incomplete; plenty of experimental and clinical studies have shown that aldosterone plays a pivotal role in a variety of (patho-) physiologic conditions within the cardiovascular continuum. Deleterious effects include cardiovascular inflammation, endothelial dysfunction, structural and electrical remodelling. Mineralocorticoid receptor antagonists (MRAs), such as spironolactone and eplerenone, prevent some of these maladaptive effects on the cardiovascular system and have proven to be a highly efficacious pharmacological therapy. In this article we review the current clinical impact of MRAs in the treatment of coronary artery disease (CAD) and its related complications, for example, acute myocardial infarction (MI) and chronic heart failure.
Carolin Zwadlo; Johann Bauersachs
Related Documents :
3599084 - Conjugated dienes in ischemic and reperfused myocardium: an in vivo chemical signature ...
11568074 - Overexpression of interleukin-1 receptor antagonist provides cardioprotection against i...
19007664 - Chapter 7. mouse models of ischemic angiogenesis and ischemia-reperfusion injury.
15308554 - Carbon monoxide protects against cardiac ischemia--reperfusion injury in vivo via mapk ...
17670664 - Should clopidogrel be stopped prior to urgent cardiac surgery?
9869964 - Alterations in heart rate following radiofrequency ablation in the treatment of reentra...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-17
Journal Detail:
Title:  Current opinion in pharmacology     Volume:  -     ISSN:  1471-4973     ISO Abbreviation:  Curr Opin Pharmacol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100966133     Medline TA:  Curr Opin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier Ltd. All rights reserved.
Department of Cardiology and Angiology, Hannover Medical School, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acute Vision Loss: A Fuzzy Presentation of Sarcoidosis.
Next Document:  Controversies about effects of low-kilovoltage MDCT acquisition on Agatston calcium scoring.